Companies / Prelude Therapeutics Incorporated
Prelude Therapeutics Incorporated
Nasdaq: PRLDCIK 1678660WILMINGTON, DE
Financials · FY2025
Ownership
79.8M shares outstanding · as of Aug 6, 2026
Ownership
| Insiders | 1.41% | 1,126,126 |
| 10%+ / strategic | 8.11% | 6,475,882 |
| Institutions | 27.56% | 21,990,311 |
| Public float | 62.92% | 50,211,166 |
% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.
Insiders 20
View all →| Insider | % of shares | Shares |
|---|---|---|
RA Capital Management, L.P.10% owner | 8.11% | 6,475,882 |
Orbimed Advisors LLCDirector · 10% owner | 1.41% | 1,126,126 |
667, L.P.Director · 10% owner | — | — |
Baker Bros. Advisors (GP) LLCDirector · 10% owner | — | — |
Baker Bros. Advisors LPDirector · 10% owner | — | — |
Baker Brothers Life Sciences LPDirector · 10% owner | — | — |
Baker FelixDirector · 10% owner | — | — |
Baker JulianDirector · 10% owner | — | — |
Brusky Sean P.Chief Business Officer | — | — |
Combs AndrewChief Chemistry Officer | — | — |
Institutional holders 51
View all →| Holder | Value | % of shares |
|---|---|---|
| $37.31M | 13.67% | |
| $34.62M | 12.69% | |
| $9.58M | 2.25% | |
| $4.10M | 1.77% | |
| $3.16M | 1.16% | |
| $2.29M | 0.99% | |
| $2.29M | 0.54% | |
| $1.62M | 2.64% | |
| $1.31M | 0.48% | |
| $1.23M | 0.45% |
Activity
Jun 30, 2026View all →
InsidersInstitutions
Who's accumulating and trimming this stock (13F).| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Q2 2026 as of | BlackRock, Inc. 13F manager | Add | — | $8.16M | +1.5M +575.04% | 1,797,501 2.25% of shares | medium |
| Q2 2025 as of | Boxer Capital Management, LLC 13F manager | Exit | — | $-1.62M | -2.1M -100.00% | — | low |
| Q2 2026 as of | State Street Corporation 13F manager | Add | — | $1.61M | +301K +236.85% | 428,787 0.54% of shares | low |
| Q1 2026 as of | Millennium Management LLC 13F manager | Add | — | $792.6K | +232K +153.47% | 382,737 0.48% of shares | low |
| Q1 2026 as of | TD Asset Management Inc 13F manager | Exit | — | $-465.9K | -161K -100.00% | — | low |
| Q1 2026 as of | Two Sigma Investments, LP 13F manager | Add | — | $461.5K | +135K +17.11% | 923,626 1.16% of shares | low |
| Q1 2023 as of | Barclays PLC 13F manager | Trim | — | $-458.9K | -81K -88.64% | 10,322 0.01% of shares | low |
| Q1 2026 as of | Marshall Wace, LLP 13F manager | Add | — | $290.8K | +85K +31.04% | 358,906 0.45% of shares | low |
5%+ ownership events
Schedule 13D / 13G
| Filer | Stance | % of class |
|---|---|---|
| Vaddi Krishna | Passive13G/A | — |
| RA Capital Management, L.P. | Passive13G | — |
Securities
via CUSIP / OpenFIGI
| Symbol | Type | CUSIP |
|---|---|---|
| PRLD | — | 74065P101 |